Inhibitory effect of lomerizine, a prophylactic drug for migraines, on serotonin-induced contraction of the basilar artery

Journal of Pharmacological Sciences

Volumn 111, Issue 2, 2009, Pages 221-225

  Ishii, Masakazu ^a   Kobayashi, Shunsuke ^a   Ohkura, Masamichi ^b   Yamamoto, Ryuichi ^c   Shimizu, Shunichi ^a   Kiuchi, Yuji ^a  

^a SHOWA UNIVERSITY   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

Basilar artery; Lomerizine; Serotonin (5 hydroxytryptamine)

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; LOMERIZINE; NIFEDIPINE; POTASSIUM ION; SEROTONIN; SEROTONIN 2A RECEPTOR; SEROTONIN ANTAGONIST; VERAPAMIL; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; BASILAR ARTERY; CELL STRAIN HEK293; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; ION CURRENT; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROPHYLAXIS; RAT; VASOCONSTRICTION;

EID: 70350515495     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.09205SC     Document Type: Article

References (15)

1. Igarashi H. [Prophylactic treatment of migraine.] Nippon Rinsho. 2005;63:1809-1814. (text in Japanese with English abstract)
2. Solomon GD, Steel JG, Spaccavento LJ. Verapamil prophylaxis of migraine. A double-blind, placebo-controlled study. JAMA.1983;250:2500-2502.
3. Markley HG, Cheronis JC, Piepho RW. Verapamil in prophylactic therapy of migraine. Neurology. 1984;34:973-976.
4. Shukla R, Garg RK, Nag D, Ahuja RC. Nifedipine in migraine and tension headache: a randomised double blind crossover study. J Assoc Physicians India. 1995;43:770-772.
5. McArthur JC, Marek K, Pestronk A, McArthur J, Peroutka SJ. Nifedipine in the prophylaxis of classic migraine: a crossover, double- masked, placebo-controlled study of headache frequency and side effects. Neurology. 1989;39:284-286. (Pubitemid 19059325)
6. Demarin V, Rundek T, Podobnik-Sarkanji S, Lovrencic-Huzjan A. A correlation of 5-hydroxytriptamine and cerebral vasoreactivity in patients with migraine. Funct Neurol. 1994;9:235-245.
7. Salomone S, Morel N, Godfraind T. Role of nitric oxide in the contractile response to 5-hydroxytryptamine of the basilar artery from Wistar Kyoto and stroke-prone rats. Br J Pharmacol. 1997;121:1051-1058. (Pubitemid 27303571)
8. 2A receptor expressed in HEK293 cells. Eur J Pharmacol. 2005;518:18-21.
9. 2+ entry, in rat β-cell line RIN-5F. J Pharamacol Sci. 2006;101:174-178.
10. Itoh T, Satoh S, Ishimatsu T, Fujiwara T, Kanmura Y. Mechanisms of flunarizine-induced vasodilation in the rabbit mesenteric artery. Circ Res. 1987;61:446-454. (Pubitemid 17145951)
11. 2+ influx via human Trp3 stably expressed in human embryonic kidney (HEK)293 cells. J Biol Chem. 1998;273:133-142.
12. Nagai S, Tsurumaki T, Abe H, Higuchi H. Functional serotonin and histamine receptor subtypes in porcine ciliary artery in comparison with middle cerebral artery. Eur J Pharmacol. 2007;570:159-166. (Pubitemid 47247685)
13. Silva SA, Marques FB, Fontes Ribeiro CA. Characterization of the human basilar artery contractile response to 5-HT and triptans. Fundamen Clin Pharmacol. 2007;21:265-272.
14. 2+ channel blocker, KB-2796, on 5-HT-induced responses.] Folia Pharmacol Jpn (Nippon Yakurigaku Zasshi). 1994;104:19-29. (text in Japanese with English abstract)
15. 2+ responses in mesangial cells. Naunyn Schmiedebergs Arch Pharmacol. 1997;356:240-247.